Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Assets (2016 - 2025)

Medifast (MED) has disclosed Current Assets for 16 consecutive years, with $201.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 5.93% year-over-year to $201.7 million, compared with a TTM value of $201.7 million through Dec 2025, down 5.93%, and an annual FY2025 reading of $201.7 million, down 5.93% over the prior year.
  • Current Assets was $201.7 million for Q4 2025 at Medifast, down from $207.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $324.3 million in Q1 2022 and bottomed at $201.7 million in Q4 2025.
  • Average Current Assets over 5 years is $241.7 million, with a median of $224.6 million recorded in 2024.
  • The sharpest move saw Current Assets surged 74.83% in 2021, then decreased 28.97% in 2023.
  • Year by year, Current Assets stood at $306.9 million in 2021, then dropped by 27.4% to $222.8 million in 2022, then increased by 0.56% to $224.0 million in 2023, then fell by 4.3% to $214.4 million in 2024, then dropped by 5.93% to $201.7 million in 2025.
  • Business Quant data shows Current Assets for MED at $201.7 million in Q4 2025, $207.8 million in Q3 2025, and $206.4 million in Q2 2025.